5 Healthcare Stocks Near the Top of Cheyne Capital’s Portfolio
London-based Cheyne Capital recently disclosed its U.S. equity portfolio via a 13F filing submitted with the SEC.
Posts Tagged ‘NYSE:ABT’
Did Hedge Funds Anticipate These M&A Deals?
Antitrust regulations, tax rules and political uncertainty marred the Merger & Acquisitions (M&A) activity in the second quarter of 2016.
How Investors Reacted to The Latest Earnings Reports of These Companies
Most investors are smiling today, as the US stock market continues its rally, with the Dow setting a new intraday high.
Here’s Why Amazon, Tesla, and Three Other Stocks Are Trending Today
Some potential upside/downside catalysts in the upcoming week include today's EIA inventory release and tomorrow's jobless claims report.
This Health Care Dividend Aristocrat Will Profit From Old Age – Globally
The world is aging. The average global population age is increasing.
Source: The Economist
This means there are more middle-aged and elderly people than ever before. This trend is expected to continue far into the future.
Citigroup (C) Supplanted Atop Diamond Hill Capital’s Portfolio in Q1
Founded in 2000 by Ric Dillon, Diamond Hill Capital employs a value investing approach to stock picking and had approximately $18 billion in assets under management at the end...
Here’s Why Traders Are Buzzing About These Five Hot Stocks
The S&P 500 opened lower on Thursday as investors refocus on the weak global macro-economic picture.
HealthCor Management Likes These 5 Healthcare Stocks Amid Sector Turbulence
Arthur B. Cohen and Joseph Healey's HealthCor Management has nearly $2.6 billion worth of regulatory assets under its management.
Dividend Aristocrats Part 30: Abbott Laboratories (ABT)
Abbott Laboratories has been wildly successful in its long history. The company’s success is not a historical relic; Abbott has positioned itself well to take advantage of...
Is Abbott Laboratories (ABT) A Good Stock To Buy?
Like everyone else, elite investors make mistakes.
St. Jude Medical, Inc. (STJ) Shares Rally Following Mistaken Report Of Acquisition Bid From Abbott Laboratories (ABT)
A report from Financial Times mentioning a potential acquisition bid for St. Jude Medical, Inc.
The 10 Most Recession-Proof Dividend Aristocrats
Unfortunately, most investors don’t know about the market-beating returns of Dividend Aristocrats during recessions. In 2008, the S&P 500 fell around 37%.
Zoetis Inc (ZTS) Avoids Possible Fight By Adding Two Members From Activist Side
Animal health care company, Zoetis Inc (NYSE:ZTS) is doing extremely well according to activist investor Bill Ackman of Pershing Square, having agreed to add two members to the...
How To Earn 13.2% Yields From Stocks Paying 5.4%
The story was picked up by the major news sources a few years ago as a "cute" human interest feature.
Danaher Corporation (DHR), General Electric Company (GE): Johnson & Johnson (JNJ) Looks to Turn the Fading Ortho Diagnostics Unit Into Cash
While Foolish readers know all too well that a good turnaround story can drive excellent shareholders, sometimes discretion is the better part of valor and it makes more sense...
Dr. Reddy’s Laboratories Limited (ADR) (RDY), Abbott Laboratories (ABT): Positive Outlook for the Generic Version of Depakote ER
Since 1983, Depakote ER has been a good source of revenue for drug manufacturers. The drug is mainly used in the treatment of bipolar disorder, migraines, and seizures.
Abbott Laboratories (ABT): Is Boston Scientific Corporation (BSX) Destined for Greatness?
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Third Obesity Drug Moves Closer to FDA Approval
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s Belviq, VIVUS, Inc. (NASDAQ:VVUS)'s Qsymia, and Orexigen Therapeutics, Inc. (NASDAQ:OREX)'s Contrave were rejected by the Food and...
Medtronic, Inc. (MDT), Abbott Laboratories (ABT): Should You Trust This Top Health-Care Dividend?
The medical-device industry isn't probably the first place you'd think to find great, high-yielding dividend stocks.
Stryker Corporation (SYK): Hedge Fund and Insider Sentiment Unchanged, What Should You Do?
To the average investor, there are a multitude of metrics shareholders can use to analyze stocks. Some of the most useful are hedge fund and insider trading movement.
Hedge Funds Are Crazy About Medtronic, Inc. (MDT)
Now, according to many of your fellow readers, hedge funds are perceived as useless, old investment vehicles of a period lost to current times.
Mead Johnson Nutrition CO (MJN), Abbott Laboratories (ABT): How to Play Emerging Market Growth Safely
The benefits to investing in emerging markets have become well known over the course of the last decade.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): Profit From The Market’s Misunderstanding Of This Spinoff Company
When a company is spun off, there's a high level of forced selling.
You Should Be Crazy About Abbott Laboratories (ABT)
Now, according to many of your fellow readers, hedge funds are viewed as delayed, outdated investment vehicles of a period lost to current times.
OraSure Technologies, Inc. (OSUR), Abbott Laboratories (ABT), Alere Inc (ALR): A Closer Look at the Market for Home and Lab HIV Tests
It is often said that the real cure for HIV and AIDS will come from better, more discrete testing procedures, and not from the drug cocktails made by Gilead Sciences, GlaxoSmithKline...
GlaxoSmithKline plc (ADR) (GSK), Abbott Laboratories (ABT): China’s Murky Business Climate Won’t Clear Up Soon
A strong week for investors ended especially well in China, as Hong Kong's HANG SENG INDEX (INDEXHANGSENG:HSI) index jumped by 3.3% for the week.
Berkshire Hathaway Inc. (BRK.B), Abbott Laboratories (ABT): The S&P 500’s 5 Most Loved Stocks
These days there doesn't seem to be much in the way of economic news that can stop the ascent of the broad-based S&P 500 .
Better Dividend: Abbott Laboratories (ABT) vs. AbbVie Inc (ABBV)
High yields aren't everything when you're searching for the perfect dividend stock.
This Acquisition Will Improve Abbott Laboratories (ABT)’s Business
Abbott Laboratories (NYSE:ABT)' bid to acquire IDEV Technologies by end-2013 will strengthen the former’s medical devices (Abbott Vascular) business especially in stent offerings...
Abbott Laboratories (ABT), Eli Lilly & Co. (LLY): Healthcare Stocks to Consider Buying
Note: This article has been amended to remove TRADJENTA as Eli Lilly & Co.
Sinopec Shanghai Petrochemical Co. (ADR) (SHI), Abbott Laboratories (ABT): The Trends Investors Need to Watch in China’s Slowdown
A downbeat outlook from China's manufacturing sector couldn't hold back Hong Kong's HANG SENG INDEX (INDEXHANGSENG:HSI) from big gains this week, as the index pulled in gains...
Will AbbVie Inc (ABBV) Earnings Stay Healthy?
AbbVie Inc (NYSE:ABBV) will release its quarterly report on Friday, and with its stock having jumped considerably since it started trading as a separate entity, investors are ...
Abbott Laboratories (ABT) & ThermoGenesis Corp (KOOL): Two Medical Device Companies Making Smart Acquisitions
Due to the aging population in developed nations, rising incomes levels in emerging nations, and overall higher government spending in the healthcare sector, the medical industry...
Better Dividend: Johnson & Johnson (JNJ) vs. Abbott Laboratories (ABT)
Picking the best dividend stocks isn't just a matter of finding the highest-yielding picks.
The Procter & Gamble Company (PG), The Walt Disney Company (DIS): Five Stocks Every Parent Should Own
It's not just Kate Middleton and Prince William having a baby these days. There are a lot of new parents and parents-to-be out there.
Gilead Sciences, Inc. (GILD), AbbVie Inc (ABBV), Bristol Myers Squibb Co. (BMY): Three Future Winners and One Major Loser in the HCV Wars
The biotech industry is a cutthroat one, with companies constantly racing to get new treatments approved by the FDA ahead of their rivals.
Abbott Laboratories (ABT), Pfizer Inc. (PFE): How Will the Patent Cliff Affect These Pharmaceuticals?
The pharmaceutical sector is mainly about the pipeline of new products and patents.
Good Nutrition Helps Abbott Laboratories (ABT)’s Q2 Earnings Grow
Investors looking to find out how well Abbott Laboratories (NYSE:ABT) performed in the second quarter had reason to be confused this morning.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): Why Investors Should Care About Hepatitis C
Hepatitis C, caused by the hepatitis C virus (HCV), is an infectious disease affecting the liver.
Mead Johnson Nutrition CO (MJN), Abbott Laboratories (ABT): Which Infant Formula Stock is a Best Buy Now?
I always consider a short-term stock price decline to be an opportunity for investors to accumulate a company’s shares at a low price.
Mead Johnson Nutrition CO (MJN): Is This Company’s Cash Cow Drying Up?
Shares of Mead Johnson Nutrition CO (NYSE:MJN) plunged recently, after Chinese regulators stated that they were investigating claims that foreign companies were intentionally...
Altria Group Inc (MO), Philip Morris International Inc. (PM): How to Play a Stronger Dollar, or Hedge Against a Falling One
Back in late March the head of US equity strategy for Deutsche Bank, David Bianco, stated that, "I’d welcome a stronger dollar...
Abbott Laboratories (ABT), AbbVie Inc (ABBV): 6-Month Checkup
Technically, Abbott Laboratories (NYSE:ABT) has been around for decades.
VIVUS, Inc. (VVUS): Obesity Drug Finally Hits Pharmacies
After gaining Food and Drug Administration approval nearly a year ago, patients can finally walk into a pharmacy and get their prescription for VIVUS, Inc.
Johnson & Johnson (JNJ), Bristol Myers Squibb Co. (BMY): Top Dividend Stocks in Big Pharma
When looking for the best dividend stocks, it's usually best to not chase the highest dividend.
Is the Time Ripe to Buy Johnson & Johnson (JNJ) Stock?
If you owned Johnson & Johnson (NYSE:JNJ) stock at the beginning of 2013, you're sitting atop gains of more than 20% right now.
Aegerion Pharmaceuticals, Inc. (AEGR), Arena Pharmaceuticals, Inc. (ARNA): Investment Opportunities in Drug Launches
There are investment opportunities in every sector, but biotechs launching new drugs offer a unique investment opportunity to take advantage of hyper-growth as sales increase ...
Abbott Laboratories (ABT), AbbVie Inc (ABBV): This Healthcare Giant is Definitely a Great Buy Now
I am always excited when a company plans to return more cash to its shareholders in both dividends and share buybacks.
Is Now a Great Time to Buy Abbott Laboratories (ABT)?
There's no question that Abbott Laboratories (NYSE:ABT) started 2013 with a bang. The year began with the spinoff of AbbVie Inc (NYSE:ABBV).
Abbott Laboratories (ABT), AbbVie Inc (ABBV): This FDA Approval Is Exciting News for Hepatitis-C Patients
Hepatitis-C is a contagious virus that attacks the liver and can be found in acute or chronic forms.
